pfizer glp-1 agonist Danuglipron: An Oral GLP-1R Competing with Peptide Injectables for Diabetes and Obesity Comparing Ozempic, Wegovy and Other

In a recent study, researchers found that GLP-1RA medications such as Ozempic and Wegovy are associated with a higher risk of post-endoscopy aspiration pneumonia.

Discover how microdosing GLP-1s can have low side effects, low costs, and support weight loss

Find out who shouldn't take Mounjaro or Wegovy

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk

Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool

Learn how they work, how they differ, whether they can be combined, and what side effects to watch for.